Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
KRAS G12D INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/274383
Kind Code:
A1
Abstract:
A KRAS inhibitor compound represented by formula (I), and an isomer or a pharmaceutically acceptable salt thereof. The compound represented by formula (I) and the composition thereof can effectively treat diseases related to KRAS mutation.

Inventors:
WANG FENG (CN)
WANG JINGLU (CN)
ZHANG CHUANXIU (CN)
ZHOU FENG (CN)
ZHANG MAN (CN)
GAO DAXIN (CN)
Application Number:
PCT/CN2022/103056
Publication Date:
January 05, 2023
Filing Date:
June 30, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI DE NOVO PHARMATECH CO LTD (CN)
International Classes:
C07D498/22; A61K31/553; A61P35/00; C07D519/00
Domestic Patent References:
WO2022173678A12022-08-18
WO2019179515A12019-09-26
Foreign References:
CN112074520A2020-12-11
CN112745335A2021-05-04
CN110603258A2019-12-20
CN202110752493A2021-07-02
CN202110873254A2021-07-30
CN202111062878A2021-09-10
CN202111398357A2021-11-19
CN202210042057A2022-01-14
CN202210675157A2022-06-15
Other References:
JONATHAN ET AL., NATURE REVIEWS, vol. 15, 2016, pages 771 - 785
ZENKER ET AL., J MED GENET, vol. 44, 2007, pages 131 - 135
CANCER DISCOVERY, vol. 7, no. 8, 2017, pages 818 - 831
"McGraw-Hill Dictionary of Chemical Terms", 1984, MCGRAW-HILL BOOK COMPANY
ELIEL, E.WILEN, S.: "Stereochemistry of Organic Compounds", 1994, JOHN WILEY & SONS, INC
BERGE ET AL.: "Pharmaceutically acceptable salts", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: